Chengdu Zenitar Biomedical Technology Co., Ltd

This study is testing an experimental drug called Purinostat mesylate in patients with advanced T-cell lymphomas that have returned or stopped responding to standard treatments. The main goal is to see if the drug can shrink tumors and control the disease. Researchers will also c…

This study is testing a new drug called purinostat mesylate for people with a type of aggressive blood cancer called diffuse large B-cell lymphoma (DLBCL) that has come back or hasn't responded to previous treatments. The main goal is to find a safe and effective dose and see how…